The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia.
This Commentary provides a state of the art for array-based karyotyping in cancer diagnostics.
Gunn
Shelly R
SR
Combimatrix Molecular Diagnostics, Irvine, CA, USA. sgunn@cmdiagnostics.com
D015415:Biomarkers / Q000032:analysis*; D019411:Clinical Laboratory Techniques; D006801:Humans; D007621:Karyotyping / Q000379:methods*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000235:genetics; D046228:Microarray Analysis / Q000379:methods*; D011379:Prognosis
D015415:Biomarkers